Liver Neoplasms
162
18
24
69
Key Insights
Highlights
Success Rate
79% trial completion
Published Results
20 trials with published results (12%)
Research Maturity
69 completed trials (43% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
11.1%
18 terminated out of 162 trials
79.3%
-7.2% vs benchmark
9%
15 trials in Phase 3/4
29%
20 of 69 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 69 completed trials
Clinical Trials (162)
CT Volumetry and Hepatic Vascular Deformation Mapping to Predict Post-Hepatectomy Liver Failure
Intraoperative Continuous Terlipressin Infusion is Associated With Reduced Severe Postoperative Complications After Laparoscopic Hepatectomy: a Prospective Propensity Score-matched Cohort Study
Dendritic Cell-immunotherapy for Advanced Hepatocellular Carcinoma
TheraSphere Japan Pre-Market Study
Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.
Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)
ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinoma
Hepatic Artery Infusion Chemotherapy Plus Donafenib in Patients With Hepatocellular Carcinoma After Surgery
Erector Spinae Plane Block Versus Thoracic Epidural Analgesia for Open Liver Resection
Translation of Acoustic Angiography: Contrast Enhanced Super Resolution (CESR) Imaging
Feasibility and Safety of Augmented Reality (AR) in Liver Tumor Surgery
A Subharmonic-Aided Pressure Estimate Technology for Prediction of Response to Systemic Therapy in Gastric Cancer Liver Metastases
A Prospective Study of a Subharmonic-Aided Pressure Estimate Technology for Early Prediction of Response to Systemic Therapy in Colorectal Cancer Liver Metastases
Efficacy and Safety of Multimodal Ablation Combined With PD-1 Monoclonal Antibody, Lenvatinib and TACE in the Treatment of Unresectable Primary Hepatocellular Carcinoma: A Single-Arm, Single-Center Clinical Study
Outcomes After Liver and Biliary Resection at a High-Volume Center
Enhanced Radiofrequency Ablation for Recurrent HCC Post-TACE Using Twin Internally Cooled-Perfusion Electrodes
A Study to Evaluate the Tolerability, Safety, and PK of AST-201 in Patients With GPC3-positive Advanced Solid Tumors
A Study of E7386 in Combination With Other Anticancer Drug(s) in Participants With Solid Tumor
Feasibility Study of Non-Contact Imaging-Based Physiological Monitoring in the Operating Room
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study